2025 Annual Results

Acceleration Confirmed

• Sales: 44.05 billion euros, +4.0% like-for-like¹ and +1.3% reported.
• Another year of outperformance in an improving beauty market.
• Growth¹ in all Divisions, led by Professional Products.
• Growth¹ in all regions witha broad-based acceleration in the second half.
• E-commerce² growing double digits passing the 30% mark.
• Gross margin up +10 basis points at 74.3%.
• Operating margin up +20 basis points at 20.2%.
• Earnings per share³ 12.71 euros, up +0.4%.
• Dividend per share⁴ 7.20 euros, up +2.9%.
• Net cash flow: 7.2 billion euros, up +7.8%.
• Sustainability leader: The only company in the world to be awarded a triple ‘A’ rating by CDP for ten years in a row. Ranked in the global top 1% for environmental and social performance by EcoVadis.

Commenting on the figures, Nicolas Hieronimus, CEO of L'Oréal, said:

“2025 was a defining year for L’Oréal: we delivered strong results regardless of the context, while profoundly transforming the Group.

As we had promised, organic top-line growth⁵ accelerated quarter after quarter, boosted by the step-up in our launch plan and supported by a gradually improving beauty market. At +4%¹, L’Oréal grew once again ahead of the market; a key highlight was the strong second-half recovery in our two largest countries, the US and China, while we continued our Emerging conquest. We delivered another year of record gross and operating margins as our focus on efficiency gains allowed us to offset adverse currency and tariff trends.

At the same time, we made L’Oréal stronger than ever through our transformation. We continued to advance on AI, strengthen our R&I capabilities and implement our IT transformation. And we embarked on our most strategic and transformational M&A offensive to date: Kering Beauté will further bolster our leadership in luxury beauty, adding highly desirable brands with significant growth potential. The increase in our stake in Galderma will allow L’Oréal to take part in the fast-growing market of aesthetics, a key adjacency to our beauty business.

This transformation opens new growth opportunities, and we are set up for further acceleration. In 2026, despite the macro uncertainties, we are optimistic about the outlook for the global beauty market, and confident in our ability to keep outperforming it thanks to L’Oréal’s multi-division category strategy and to achieve another year of growth in sales and profit.” 

Board appointments and renewals 

Meeting on 12 February 2026, the Board of Directors, decided to submit to the Annual General Meeting on 24 April 2026 the renewal of the mandates of Mr Jean-Paul Agon and Mr Patrice Caine as Directors for a four-year term.

Furthermore, the Board decided to maintain the separation of the roles of Chairman of the Board and Chief Executive Officer. Subject to the approval of the renewal of his mandate as Director by the Annual General Meeting, Mr Jean-Paul Agon will be reappointed as Chairman of the Board of Directors following the Annual General Meeting on 24 April 2026.

The Board of Directors took note of the decisions of Mr Paul Bulcke and Ms Béatrice Guillaume-Grabisch to terminate their mandates as Directors at the end of the Annual General Meeting on 24 April 2026.

Mr Paul Bulcke, Director from 2012 to 2014 and since 2017, is Vice-Chairman of the Board of Directors and a member of the Strategy and Sustainability Committee, the Nominations and Governance Committee and the Human Resources and Remuneration Committee.

Mr Jean-Paul Agon, on behalf of the Board of Directors, warmly thanked Mr Paul Bulcke for his total commitment and his significant contribution to the work of L’Oréal’s Board and its Committees for more than a decade. His strategic vision, his enlightened multicultural approach and his constant interest in innovation have been particularly valuable in addressing the major challenges of recent years.

Ms Béatrice Guillaume-Grabisch has been a Director and member of the Audit Committee since 2016. The Board acknowledged the commitment and active contribution of Ms Béatrice Guillaume-Grabisch to the work of the Board and the Audit Committee during her 10-year mandate. Her experience in general management in the consumer goods sector, her marketing expertise and her recognised skills in steering IT transformation have enriched the work of the Board and the Audit Committee.

On the proposal of Nestlé and on the recommendation of the Nominations and Governance Committee, the Board of Directors is submitting to the Annual General Meeting the appointments of Mr Pablo Isla and Ms Anna Lenz as Directors for a four-year term.

Mr Pablo Isla is Chairman of the Board of Directors of Nestlé SA. A lawyer by training, he led Inditex (an international fashion group with several brands including Zara) for 17 years, first as Deputy Chairman and CEO from 2005, then as Executive Chairman from 2011 to 2022. Mr Pablo Isla will bring to the Board his recognised ability to develop and implement a strategic vision combining transformation and growth at an international level, his solid understanding of regulatory and risk management issues, and his in-depth knowledge of corporate governance.

Subject to his appointment as a Director, the Board of Directors has decided to appoint Mr Pablo Isla as Vice-Chairman of the Board of Directors, alongside Mr Jean-Victor Meyers, who is also Vice-Chairman of the Board, following the Annual General Meeting of 24 April 2026.

Ms Anna Lenz is Executive Vice President and Global Head of Human Resources of Nestlé and a member of the Executive Board, after a career of more than 20 years within the Group. Ms Anna Lenz will bring to the Board a holistic understanding of an international group. Her expertise in human resources management, as well as her proven experience in steering financial performance and in operations management in complex environments, will be major assets for the work of the Board.

The Board of Directors, on the recommendation of the Nominations and Governance Committee, also submits to the Annual General Meeting the appointment of Ms Christel Bories as a Director for a period of 4 years.

Ms Christel Bories is Chairwoman of the Board of Directors of Eramet, a global mining and metallurgical group, for which she has also been acting as interim Chief Executive Officer since February 2026. Previously, she held the positions of Deputy Chief Executive Officer of Ipsen Pharma, Chief Executive Officer of Constellium and senior executive at Pechiney and Alcan. Ms Christel Bories will bring to the Board her experience as a director of international companies in various sectors such as industry, packaging and healthcare. Her in-depth knowledge of raw materials, industrial value chains, ESG and her significant experience of the issues on all continents, particularly in Africa, will be a valuable addition to the work of the Board.

If the Annual General Meeting approves the proposed appointments and renewals, the Board of Directors will be composed of 18 Directors, i.e. 16 Directors appointed by the Annual General Meeting and 2 Directors representing the employees. The balance in terms of independence and diversity will be as follows:

• 9 independent Directors out of 16 appointed by the Annual General Meeting, i.e. 56%,
• 7 women and 9 men out of 16 Directors appointed by the Annual General Meeting, i.e. 44% women.

PROJECTED COMPOSITION OF THE BOARD AND COMMITTEES FOLLOWING THE GENERAL MEETING OF APRIL 24, 2026*

*Assuming the General Meeting of April 24, 2026 approves the proposed appointments and renewals.

**Excluding Directors representing the employees, in accordance with the French Commercial Code (Code de commerce) and the AFEP-MEDEF Code.

*** In accordance with L’Oréal’s Articles of Association, the Directors representing employees are appointed as follows: one by the most representative trade union organization in France, and the other by the European Works Council. Their terms of office were set to expire at the close of the 2026 Annual General Meeting. Mr. Benny de Vlieger’s mandate was renewed by the European Works Council. As Mr. Thierry Hamel has decided to retire, his term will end at the close of the 2026 Annual General Meeting. The CFE-CGC has appointed Ms. Catherine Olivry as a Director representing employees, effective from the date of the General Meeting. Until now, Ms. Catherine Olivry served as a representative of the Central Social and Economic Committee (CSEC) to the Board of Directors.

2025 SALES

Salesamounted to 44.05 billion euros at 31 December 2025, up +1.3% reported.

Like-for-like, i.e. based on a comparable structure and identical exchange rates, sales grew by +4.0%.

The net impact of changes in the scope of consolidation was +0.9%.

Growth at constant exchange rates came out at +4.9%. 

Currency fluctuations had a negative impact of -3.6% at the end of 2025.

Sales by Division and Region

Summary by Division

PROFESSIONAL PRODUCTS

The Professional Products Division posted growth of +7.5% like-for-like and +5.7% reported.

It significantly outperformed the professional beauty market, growing in volume and value. Sales passed the €5bn threshold for the first time. It was boosted by the sustained momentum in premium haircare and the successful rollout of the omnichannel strategy – with an acceleration in both e-commerce and selective distribution – while focusing on reigniting the salon market through tailored salon services.

The Division grew across all regions, fuelled by its strong performance in Europe and China as well as its continued expansion in emerging markets, notably Brazil, Mexico, GCC⁷ and India.

In a very dynamic premium haircare market, Kérastase recorded another year of remarkable double-digit growth propelled by Gloss Absolu, the Division’s biggest-ever launch. In hair colour, Professional Products continued to bring strong innovations, including Matrix Super Sync and the successful relaunch of Majirel by L'Oréal Professionnel.

The integration of Color Wow is well underway: this strategic acquisition brings increased firepower in the fast-accelerating styling segment and will open significant opportunities for international expansion.

CONSUMER PRODUCTS

The Consumer Products Division posted growth of +3.5% like-for-like and +0.7% reported.

Growth accelerated between first and second half reflecting the successful step-up in innovation, particularly haircare and makeup.

All four global brands grew: L’Oréal Paris, the number one beauty brand in the world, and NYX Professional Makeup had another strong year. Among the regional brands, stand-out performances came from Mixa with its successful European roll out, and 3CE with its expansion throughout Southeast Asia. The recently acquired Dr.G brand has been successfully integrated.

In North America, growth saw a remarkable acceleration: the Division significantly outpaced the market, notably in makeup and haircare, driven by innovation and its new go-to-market organisation. In emerging markets, momentum was strong, led by Brazil, Mexico, GCC⁷, and Vietnam. In Europe, growth remained solid with particularly noteworthy performances in Southern Europe.

Haircare advanced in double digits and was the Division’s single biggest growth contributor, propelled by the continued success of L’Oréal Paris Glycolic Gloss and the launch of Garnier Fructis Curl Method. In a soft makeup market, growth was boosted by blockbusters like Maybelline New York Colossal Bubble Mascara, L’Oréal Paris Infallible Setting Spray, and NYX Lip IV. Skincare was supported by innovations from L'Oréal Paris’ Revitalift franchise, including the Eye Bag Instant Eraser, as well as Garnier Dry Touch Cream.

LUXE

L'Oréal Luxe posted growth of +2.8% like-for-like, +0.0% reported.

Momentum accelerated in the second half of the year with growth reaching +3.6% – and close to +5% outside Travel Retail in Asia, where the situation remained challenging. The Division strongly outperformed a selective market at around +1%, with a gradual improvement in the second half.

L’Oréal Luxe thus reinforced its global leadership position, anchored by a balanced regional footprint. 2025 marked a new milestone as the Division became the number one player in North Asia – securing market leadership across all regions.

The Division achieved double-digit growth in emerging markets, strongly outpaced the market in Europe – notably in the DACH and Spain/ Portugal clusters. In North America, the Division demonstrated firm resilience. In North Asia, momentum accelerated in the second half as the selective market in China returned to growth.

Fragrances remained a powerful growth engine driven by the highly dynamic Couture brands, thanks to global blockbusters like Libre and MYSLF by Yves Saint Laurent, Born in Roma by Valentino and Paradoxe by Prada – further energised by the stellar debut of Prada’s Paradigme and the solid start of Miu Miu’s Miutine. A highlight was the double-digit growth of the Fragrance Collections – led by exceptional results from Aesop and Maison Margiela. This strong momentum in Fragrances confirms the Division's successful strategy in the ultra-premium and Couture segments.

Makeup benefited from a step-up in innovation with particular successes from Yves Saint Laurent with Make Me Blush and The Inks, Prada – which delivered another year of double-digit growth, and Lancôme’s Idôle franchise with Juicy Treats.

In skincare, the recently acquired Medik8 brand is off to a strong start – reinforcing the position of L’Oréal Luxe in the important segment of medicalised beauty.

DERMATOLOGICAL BEAUTY

The Dermatological Beauty Division posted growth of +5.5% like-for-like and +2.5% reported. 

Momentum improved quarter after quarter and significantly accelerated into double digits in the fourth quarter, supported by the gradual alignment of sell-in and sell-out and the progressive turnaround of CeraVe. In sell-out, the Division continued to outperform a global dermo-cosmetics market, which decelerated but remained robust and ahead of the overall beauty category.

Dermatological Beauty advanced in all regions. Momentum was particularly strong in emerging markets and resilient in mature markets, where the Division significantly outpaced the market in sell-out.

La Roche-Posay remained the number one growth contributor. It significantly outpaced the market, driven by the Cicaplast franchise and the continued success of Melasyl, the breakthrough anti-pigmentation technology.

CeraVe achieved a gradual turnaround, boosted by the successful launch of Intensive Moisturising Lotion. In the US, the brand progressively reaccelerated in skincare and benefitted from the entry into haircare, which had a good start – allowing it to outpace the market in the second half. In emerging markets and mainland China, CeraVe pursued its very strong momentum, growing well ahead of the market.

SkinCeuticals crossed the billion-euro mark, delivering very dynamic growth everywhere, propelled by outstanding innovations like P-Tiox and AGE interrupter.

Vichy’s growth was boosted by the ongoing strength of Dercos and the successful launch of Collagen Specialist 16.

Summary by Region

EUROPE 

Sales in Europe grew +4.4 % like-for-like and +4.6% reported.

L’Oréal continued to outpace a robust beauty market, with a particularly strong finish, thanks to the continued success of e-commerce.

Momentum was especially strong in the Spain-Portugal and Germany-Austria-Switzerland clusters, Italy and in most medium-sized countries; the UK-Ireland cluster significantly accelerated in the second half.

Consumer Products outpaced the market in makeup thanks to strong innovations, notably from L’Oréal Paris and NYX Professional Make-Up. Haircare was boosted by successful launches such as L’Oréal Paris Elsève Glycolic Gloss and Garnier Fructis Keratin Sleek.

L'Oréal Luxe significantly outperformed its market, thanks primarily to the outstanding performance of its fragrance portfolio. L’Oréal holds the top 3 positions in female fragrances with Libre, La Vie est Belle and Paradoxe. In male fragrances, Prada’s Paradigme was off to a very strong start.

Professional Products grew strongly, propelled by the continued dynamism in premium haircare – with a particularly impressive performance from Kérastase.

Dermatological Beauty progressively accelerated in the second half, helped by the gradual alignment of sell-in and sell-out. La Roche-Posay cemented its leadership across its strategic channels. SkinCeuticals was particularly dynamic, fuelled by successful launches.

NORTH AMERICA

Sales in North America grew +3.4% like-for-like and -0.7% reported.

Growth accelerated from +2% in the first to almost +5% in the second half as market conditions improved and key innovations were successfully rolled out. It was broad-based with all Divisions contributing.

In Consumer Products, momentum improved quarter after quarter, resulting in significant outperformance in the back half of the year. Haircare remained the most dynamic growth engine, led by L'Oréal ParisElvive and Ever. Makeup improved strongly, driven by innovations like L'Oréal Paris’ Plump Ambition and Faux Brow, as well as NYX Professional Makeup’s Lip IV and Brow Glue Crazy Lift.

Professional Products outpaced the market thanks to the continued strength of Kérastase in premium haircare, boosted further by the successful launch of Gloss Absolu.The recently acquired Color Wow is off to a good start.

In Luxe, fragrances remained dynamic, significantly outpacing the market. The category was powered by the ongoing success of Couture brands as well as the rollout of new launches including Prada's Paradigme, Miu Miu’s Miutine and YSL’s MYSLF Absolu.

In Dermatological Beauty, momentum significantly improved in the second half of the year with all key brands contributing. Growth was led by SkinCeuticals, boosted by the continued success of P-Tiox and strong momentum in D2C. CeraVe maintained its upward trajectory, driven by continued strength in haircare and a gradual improvement in skincare.

E-commerce remained the primary growth engine, delivering robust performance across all four Divisions.

NORTH ASIA

Sales in North Asia grew +0.5% like-for-like and -2.2% reported.

Excluding Travel Retail, where the overall ecosystem remained challenging, L’Oréal’s growth improved from flat in the first to +4% in the second half. The Group outperformed in all markets, including Travel Retail, thanks to its unrivalled brand portfolio and step-up in innovation.

The improvement was driven by mainland China, where growth accelerated from low to mid-single digits over the period, supported by gradually stabilising market conditions. L’Oréal outperformed the market both online and offline. In a selective market that saw a clear recovery in the second half, Luxe continued to outperform, boosted by its strong innovation pipeline. Growth remained dynamic in Professional Products and, even more so, Dermatological Beauty, where SkinCeuticals strengthened its leadership position. L’Oréal Paris once again confirmed its position as the number one beauty brand in the Chinese market.

In North Asia, Dermatological Beauty posted double-digit growth with all brands contributing – gaining share across all markets. Professional Products outperformed the market, boosted by the ongoing strength of Kérastase and e-commerce. In Luxe, growth saw a sharp recovery in the second half and continued to outpace the market, propelled by strong innovations and outstanding consumer experiences with Yves Saint Laurent, Prada, Maison Margiela and Aesop particularly dynamic.

SAPMENA–SSA⁶

Sales in SAPMENA-SSA grew +10.9% like-for-like and +6.5% reported.

In SAPMENA, growth was broad-based with all Divisions contributing. Dermatological Beauty was the most dynamic Division, led by La Roche-Posay and CeraVe. Professional Products advanced strongly, boosted by Kérastase. The performance of Luxe was powered by Yves Saint Laurent, Armani, and Prada. Consumer Products, the region’s single largest growth contributor, was driven by L’Oréal Paris.

By category, haircare, makeup and fragrances all posted double-digit growth. Haircare led the way with strong performances in both, the professional and mass channels – the latter fuelled by successful Elsève launches. The rebound of makeup continued, boosted by innovations and the successful expansion of 3CE in the region. Fragrances grew strongly, powered by the Couture brands.

By country, key contributors were GCC⁷, followed by the Australia-New Zealand cluster, Vietnam, India, and Thailand. 

Across the region, online remained the main growth driver, notably in India, South-East Asia and GCC⁷.

Sub-Saharan Africa (SSA) demonstrated robust growth, driven by both, volume and mix. Momentum was broad-based across all Divisions: main contributors were Consumer Products and Dermatological Beauty. Skincare, haircare and makeup achieved remarkable momentum, driven by La Roche-Posay, L’Oréal Paris and CeraVe. South Africa remained the key growth contributor and continued to outpace its market.

LATIN AMERICA

Sales in Latin America grew +8.3% like-for-like and -0.7% reported.

This strong growth was achieved despite softening market conditions, demonstrating L’Oréal’s resilience. 

All Divisions advanced. Professional Products and Luxe continued to deliver outstanding growth, driven by strong innovation in premium haircare and fragrances and makeup, respectively. Consumer Products was the leading growth contributor, fuelled by haircare, makeup and hair colour, led by L’Oréal Paris, where the Elsève Dream Sleek blockbuster innovation fortified the brand’s market share throughout the region. 

All key categories advanced. Fragrances maintained exceptional momentum, powered by the Couture brands. The all-important haircare category was the number one growth contributor, advancing in double digits across all relevant Divisions and brands – boosted by a strong innovation pipeline.

Progress was broad-based across all countries, with particularly strong performances in Mexico and Brazil.

Both brick-and-mortar and online grew. E-commerce maintained its strong momentum across the region, allowing L’Oréal to reach new consumers.

IMPORTANT EVENTS SINCE THE LAST PUBLICATION

STRATEGY

• L’Oréal announced the acquisition of an additional 10% stake in Galderma, bringing its ownership to 20%. This increased investment reaffirms L’Oréal’s ambition to participate in the fast-growing aesthetics market. Galderma’s Board of Directors will consider nominating two non-independent board candidates from L’Oréal as from the 2026 Annual General Meeting. Customary regulatory approvals have been obtained, and closing was completed on February 10, 2026.

RESEARCH, BEAUTY TECH AND DIGITAL

• L’Oréal introduced two breakthrough technologies at the CES 2026 in Las Vegas, bringing the power of infrared light to hair with the Light Straight + Multi-styler and to skin with the LED Face Mask. Both were honoured with a CES® 2026 Innovation Award.
• L’Oréal announced the creation of a Beauty Tech hub in India. One of its objectives will be to develop AI-powered beauty solutions, leveraging Generative and Agentic AI.

ENVIRONMENTAL, SOCIAL AND GOVERNANCE PERFORMANCE

• L’Oréal achieved a tenth consecutive CDP triple ‘A’ score, demonstrating its commitment to leadership and transparency in climate, forests and water security.
• L'Oréal was awarded the EcoVadis Platinum medal rating with a score of 89 over 100. This recognition puts it in the top 1% of the highest-rated companies in the world among 150,000 companies assessed.

OTHER

• L’Oréal is ranked as the 41^st most admired company in the world (only French company in the Top 50) by The Fortune Most Admired Companies List. 

2025 RESULTS

Financial statements are audited and the certification report on the consolidated financial statements will be issued once the management report has been approved by the Board of Directors and verified by the Statutory Auditors.

Operating profitability at 20.2% of sales

Consolidated profit and loss accounts: from sales to operating profit.

Gross profit, at 74.3% of sales, improved by 10 basis points.

Research & Innovation expenses remained stable at 3.1% of sales.

Advertising and promotional expenses remained stable at 32.2% of sales.

Selling, general and administrative expenses decreased by 10 basis points to 18.8% of sales.

Overall, operating profit increased by +2.4% to 8,891.9 million euros, and amounted to 20.2% of sales, an improvement of 20 basis points.

Operating profit by Division

The profitability of the Professional Products Division came out at 22.9% of sales, up 70 basis points.

The profitability of the Consumer Products Division came out at 21.4% of sales, up 30 basis points.

The profitability of the Luxe Division came out at 22.4% of sales, up 10 basis points.

The profitability of theDermatological BeautyDivision came out at 26.1%, stable compared to 2024.

Non-allocated expenses amounted to 1,101.8 million euros.

Net profit

Consolidated profit and loss accounts: from operating profit to net profit excluding non-recurring items.

Net finance costs amounted to 236.1 million euros.

Dividendsreceived totalled 351.9 million euros.

Income tax excluding non-recurrent items amounted to 2,187.4 million euros, representing a tax rate of 24.3%.

Net profit excluding non-recurring items after non-controlling interests stood at 6,806.4 million euros.

Earnings per share³, at 12.71 euros, increased by +0.4%.

Non-recurring items after non-controlling interests⁹amounted to 681.1 million euros net of tax.

Net profit after non-controlling interests came out at 6,127.2 million euros, decreasing by -4.4%.

Cash flow statement, Balance sheet and Cash position

Gross cash flow amounted to 8,329.5 million euros, a decrease of -2.2%.

The working capital requirement decreased by 327 million euros.

At 1,495.3 million euros, investments represented 3.4% of sales.

Net cash flow¹⁰, at 7,161.6 million euros, increased by 7.8%.

The balance sheet remains strong, with shareholders’ equity amounting to 35.0 billion euros.

Proposed dividend at the Annual General Meeting of 24 April 2026

The Board of Directors has decided to propose a dividend of 7.20 euros per share at the shareholders’ Annual General Meeting of 24 April 2026, an increase of +2.9% compared with the dividend paid in 2025. The dividend will be paid on 4 May 2026 (ex-dividend date 29 April 2026).

Share capital

At 31 December 2025, the capital of the company is formed by 533,783,028 shares.

The L’Oréal Board of Directors met on 12 February 2026, under the chairmanship of Jean-Paul Agon and in the presence of the Statutory Auditors. The Board approved the consolidated financial statements and the financial statements for 2025.

“This news release does not constitute an offer to sell, or a solicitation of an offer to buy L’Oréal shares. If you wish to obtain more comprehensive information about L’Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our website www.loreal-finance.com.

This news release may contain some forward-looking statements. While the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, they are by nature subject to risks and uncertainties which may lead to a discrepancy between the actual figures and those indicated or suggested in these statements.”

About L’Oréal

For over 115 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as essential, inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 40 international brands and ambitious sustainability commitments in our L’Oréal for the Future programme, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality. 

With more than 95,000 committed employees, a balanced geographical footprint and sales across all distribution networks (ecommerce, mass market, department stores, pharmacies, perfumeries, hair salons, branded and travel retail), in 2025 the Group generated sales amounting to 44.05 billion euros. With 22 research centers across 9 regional hubs around the world and a dedicated Research and Innovation team of over 4,000 scientists and more than 8,000 Digital, Tech and Data talents, L’Oréal is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse. 

In 2025, L’Oréal has been named the most innovative company in Europe by Fortune magazine, out of 300 companies, in a ranking spanning 21 countries and 16 industries in Europe.

More information on https://www.loreal.com/en/mediaroom

L’ORÉAL CONTACTS

Switchboard
+33 (0) 1 47 56 70 00

Individual shareholders

Pascale Guerin

+33 (0)1 49 64 18 89

pascale.guerin@loreal.com

Investor relations

Eva Quiroga

+33 (0)7 88 14 22 65

eva.quiroga@loreal.com

Journalists

Brune Diricq

+33 (0)6 63 85 29 87

brune.diricq@loreal.com

Christine Burke

+33 (0)6 75 54 38 15

christine.burke@loreal.com

For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, the website for shareholders and investors, www.loreal-finance.com or the L’Oréal Finance app; alternatively, call +33 (0)1 40 14 80 50.

This press release has been secured and authenticated with blockchain technology. 
You can verify its authenticity on the website www.wiztrust.com

¹Like-for-like growth: based on a comparable structure and identical exchange rates.

²Includes sales on L'Oréal’s brand websites, sales to online pure players, and the e-commerce portion of sales to traditional retailers (based on non-audited declarative data); like-for-like.

³Diluted earnings per share (EPS), based on net profit, excluding non-recurring items, after non-controlling interests.

⁴To be proposed at the Annual General Meeting of 24 April 2026.

⁵Adjusted for the phasing related to the 2024 and 2025 IT transformation.

⁶ SAPMENA – SSA: South Asia Pacific, Middle East, North Africa, Sub-Saharan Africa.

⁷GCC: Gulf Cooperation Council.

⁸ Non-allocated = Central Group expenses, fundamental research expenses, free grant of shares expenses and miscellaneous items.

⁹ Non-recurring items include impairment of assets, capital gains and losses on disposals of long-term assets, restructuring costs and tax effects of non-recurring items.

¹⁰ Net cash flow = Gross cash flow + changes in working capital - capital expenditure.
 

Appendices

Appendix 1: L’Oréal group sales 2024/2025 (€ million)

Appendix 2: Compared consolidated income statements

Appendix 3: Consolidated statement of comprehensive income

1. The tax effect is as follows:

Appendix 4: Compared consolidated balance sheets

Assets

Equity & Liabilities

Appendix 5: Consolidated statements of changes in equity

⁽¹⁾ Corresponds essentially to the commitment to buy back the minority shareholders of Medik8 for €325 million.

Appendix 6: Compared consolidated statements of cash flows

1. Following the outcome in 2023 of the dispute with the French Competition Authority, the reversal of the provision and the reversal of the debt for the same amount of €189.5 million were presented in operations without impact on cash flow.

Attachment

• CP_FY25_EN_v12.02 17.00